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ity and sensitivity of the SMM.
Implications: This is a beginning program of research on visual art
and healing environments. The intervention is patient centered and
congruent with core nursing values of promoting health, healing,
and hope. If better understood, patient preferences could enhance
environments, thereby improving health outcomes.107
PREDICTIVE EFFECTS OF MALNUTRITION INDICATORS FOR MORBIDITY
ANDMORTALITY AMONG BLOOD ANDMARROWTRANSPLANTATION RE-
CIPIENTS: A RETROSPECTIVE CHART REVIEW
Lecagoonporn, S.1, Watson, M.2, Popat, U.1, Champlin, R.1,
Langford, R.2, Cesario, S.2, Young, A.2 1The University of TexasMDAn-
derson Cancer Center, Houston, TX; 2Texas Woman’s University, Hous-
ton, TX
The purpose of this study was to identify complications related to
the blood and marrow transplantation (BMT) process, the presence
of malnutrition among patients who received myeloablative alloge-
neic BMT, and the predictive effects of malnutrition indicators to
the outcomes of BMT. Four research questions related to malnutri-
tion were investigated: (a) malnutrition indicators and outcomes of
BMT; (b) body mass index (BMI) and incidences of transplant re-
lated mortality; (c) degree of mucositis and its relationship to trans-
plant related infections; and (d) predictive ability of BMI and serum
albumin levels and infection incidences during 100 days post BMT.
The conceptual framework chosen for this study is based on the
pathways of cancer aggression (1977) which demonstrate how cancer
interferes with multiple organs and function leading to host deple-
tion, morbidity, and mortality. This study is a retrospective chart re-
view from 110 electronic medical records of patients diagnosed with
Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome
(MDS), who received the same regimen of myeloablative, allogeneic
BMT from one cancer institution during August 2005 to June 2008.
Findings revealed that there were subjects who experiencedweight
loss (68%) and had hypoalbuminemia (97.3%), indicating malnutri-
tion among 110 post-allogeneic BMT recipients during the 100 days
post-BMT.Weight loss was not related to transplant mortality but it
significantly contributed to an increase in transplant related infec-
tions. Hypoalbuminemia was significantly related to both transplant
related mortality and infection especially when serum albumin drop-
ped below 3 gm/dL. The body mass index was not related to trans-
plant related mortality during 100 days post BMT. Although the
majority of subjects (71.8%) experienced mucositis to the point
that it interfered their eating and swallowing solid food, severity in
mucositis did not contribute to transplant related infection. Both
BMI and hypoalbuminemia were significant predictors to transplant
related infection during 100 days post BMT.108
ASSESSING QUALITY OF LIFE (QOL), SPIRITUAL WELL-BEING, AND USE
OF RESOURCES THROUGHOUT THE HEMATOPOIETIC STEM CELL TRANS-
PLANT (HSCT) PROCESS
Sirilla, J.A.1, Ezzone, S.A.1, Kirkendall, C.1, Buck, J.2 1Ohio State Uni-
versity James Cancer Hospital, Columbus, OH; 2Ohio State University
Medical Center, Columbus, OH
Hematopoietic StemCell Transplant (HSCT) recipients continue
to report quality of life (QOL) issues post transplant. A descriptive
study using a longitudinal design was completed at one institution.
The primary goal of the study was to describe QOL, spiritual
well-being, and use of resources pre-transplant, one month, three
months, and six months after transplant in HSCT recipients.
A conceptual model developed by Ferrell et al (1992a) described
how HSCT impacts four domains of QOL: physical, psychological,
social, and spiritual well-being. This study utilized three tools to as-sess QOL (FACT-BMT (Version 4)), spiritual well-being (FACIT-
SP-12) and the use of resources (a resource questionnaire developed
by the researchers). The resource questionnaire was tested for clar-
ity, readability, and content validity.
An IRB approved informed consent was obtained. Patients were
asked to complete baseline questionnaires and a demographic form
pre-transplant. Follow-up packets were mailed or provided in the
outpatient clinic at 1 month, 3 months, and 6 months. An addressed
stamped envelope was provided. In order tomaintain confidentiality,
the PI assigned each participant a unique alphanumeric code that ap-
peared at the top of each page of each form.
Complete data was obtained on 67 of 161 consented participants
and incomplete data was obtained on 94 of the 161. Of the 67 who
completed all the forms, 59% were male; 94% were Caucasian;
68.6% were married; all had at least a high school education and
41.7% attended school more than 12 years.
Overall QOL decreased (p 5 0.01) between baseline score (mean
103.7) and day 130 (mean 97.2), day 190 (mean 105.0) slightly ex-
ceeded baseline (p 5 0.65) and by day 1180 (mean 110.2) signifi-
cantly exceeded baseline scores (p5\ 0.001). Spiritual well being
mean baseline score (37.4) to day 1180 (37.0) did not change (p 5
0.72 to p 5 0.98). Overall use of resources increased (p 5 0.02) be-
tween baseline score (14.3) and day 130 (15.8), day 190 (14.3) and
decreased below baseline by day1180 (13.1) (p5\0.001). Although
QOLand resource utilization increasedwithHSCT, scores returned
to baseline within 6 months post transplant.109
THE QUALITY OF THE ADULT CAREGIVER-RECIPIENT RELATIONSHIP
MAY BUFFER CAREGIVER BURDEN DURING ALLOGENEIC TRANSPLAN-
TATION
Wehrlen, L.D.1, Prachenko, O.1, Prince, P.2, Foruraghi, L.3,
Shelburne, N.4, Wallen, G.R.1, Bevans, M.F.1 1NIH, Clinical Center,
Bethesda, MD; 2NIH, Clinical Center, Bethesda, MD; 3National Insti-
tute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD;
4NIH, Clinical Center, Bethesda, MD
Caregivers are critical partners in allogeneic transplantation
(HSCT) recipients’ treatment and recovery. Although many trans-
plant caregivers report significant emotional distress, factors that
might serve to buffer the impact of this experience on their lives
are not well understood. The purpose of this analysis is to examine
the quality of the HSCT caregiver-recipient relationship and its
association to caregiver perceived burden.
Methods: Cross-sectional data were drawn from HSCT recipients
and caregivers preparing for HSCT from a longitudinal study. Mea-
sures include the Family Caregiving Inventory (FCI) Mutuality
Scale, Caregiver Reaction Assessment (CRA), Distress Thermome-
ter (DT), and self-reported demographic data.
Results: Adult (M 5 52.1613.3 years) caregivers (N 5 111) were
predominantly female (73.0%), and spouse to the HSCT recipient
(45.9%). Fifty-three (47.7%) were sole caregivers while 58 (52.2%)
were members of a caregiver ‘team’. Adult (M 5 46.4614.4 years)
HSCT recipients were predominately male (62.3%), preparing for
a reduced intensity HSCT (84.4%). Caregiver mutuality was signif-
icantly related (p\0.05) to all aspects of caregiver burden except fi-
nances (p 5 0.113). Caregivers with higher mutuality reported less
impact on self-esteem, health, schedule and sense of abandonment
by family. Higher recipient mutuality was also related to less impact
on caregiver self-esteem (p\0.05). Greater agreement on perceived
mutuality was related to less impact on caregiver self-esteem (p\
0.001) and finances (p\0.05). Caregivers with less burden reported
lower levels of self-reported distress (p\ 0.05).
Conclusion:Results suggest that caregivers who perceive good rela-
tionship quality with HSCT recipients experience less burden. As-
sessments and interventions directed at understanding relationship
concernsmight improve outcomes for caregivers includingminimiz-
ing distress.
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REDUCING OUTPATIENT BMT CLINIC VISIT TIMES
Cuthrell, P.,Michael,M.A., Vaughn, G., Detzel, J.,Maier, S., Davis, K.,
Herman, E., Flesch, L., Pomales, J., Craig, S., Alvey, P., Kirkendall, S.,
Hicks, B., Simon, T., Bierman, L., Harris, M., Shah, N., Filipovich, A.,
Davies, S. Cincinnati Children’s HospitalMedical Center, Cincinnati, OH
As our health care environment faces increasing costs, high de-
mands, and shifts towards outpatient care, facilities are forced to re-
assess their operations. To manage a successful clinic, a focus must
be placed on efficient yet safe patient care delivery. Patient satisfac-
tion plays an important part of this reassessment. In our pediatric
BMT clinic, patients receive a variety of clinical care support includ-
ing f/u exams, lab draws, central line care, short infusion therapies
and new patient consults. Literature review finds that most research
has focused on studying scheduling options to reduce visit times in
the outpatient setting. Our improvement project was focused on re-
ducing overall patient visit time through changes that impacted pa-
tient flow. An Improvement Science approach was initiated by staff
and initially they looked at average clinic visit times (time of arrival
to time of discharge) for new and follow-up visits in the BMT clinic
from January - March, 2010. The staff also looked at the past parent
satisfaction survey data from our outpatient pediatric BMT clinic
which revealed that 65% of families felt wait times in exam rooms
were not acceptable. The overall aim of this project focused on de-
creasing average clinic visit time for new and follow-up BMT pa-
tients by 25%. Key drivers were identified as accurately scheduled
provider templates, adequate staffing, clear role responsibilities/
team work, accurate communication handoff and timely discharge
documentation. Key interventions included placing an APN in the
clinic provider template, developing a FlowLeadRN role with triage
and implementing the pod nursing care delivery system. Visit time
data was extrapolated and placed on a run chart to show improve-
ments made throughout the last 6 months. Run chart data showed
a shift in the mean and a reduction in overall visit time for new
and follow-up patients. Median new visits were reduced from 241
to 221 minutes. The median follow-up visits were reduced from
209 to 167 minutes. Families, staff and physicians have commented
positively on the interventions. Consistent handoffs of care/commu-
nication have led to a safer environment for patients. We are con-
tinuing to test, implement and evaluate changes to reduce visit
time and increase family satisfaction as we work to meet the goals
set with this improvement project.111
PREVENTION OF DMSO-RELATED NAUSEA AND VOMITING BY PROPHY-
LACTIC ADMINISTRATION OF ONDANSETRON FOR PATIENTS RECEIVING
AUTOLOGOUS CRYOPRESERVED PERIPHERAL BLOOD STEM CELLS
Eisenberg, S.1 1Seattle Cancer Care Alliance, Seattle, WA
Background:DMSO(dimethyl sulfoxide) is frequently used as a cry-
opreservative for peripheral blood stem cells (PBSCs). Common side
effects of this chemical include nausea, vomiting, abdominal cramp-
ing, coughing and throat irritation. A comprehensive literature
search using PubMed and CINAHL failed to reveal any studies in-
vestigating the benefit of antiemetics for preventing or reducing
DMSO-induced nausea or vomiting.
Study design: A pilot study was conducted to determine whether
a single 16mg intravenous dose of ondansetron could decrease the
degree of nausea and episodes of emesis in patients receiving autol-
ogous PBSCs cryopreserved in DMSO. Fifty patients scheduled to
receive an autologous transplant in an ambulatory NCI-designated
comprehensive cancer center were enrolled. Nausea was rated usingthe MAASC nausea scale (0-10) at the following time points: upon
arrival to the Infusion Room, prior to the ondansetron administra-
tion, prior to each cryopreserved bag, and at the end of the last
bag. Episodes of emesis were documented. Results would be com-
pared to an (unpublished) study examining the side effects of
DMSO on 60 autologous HSCT patients previously conducted by
this investigator.
Results: Forty-nine patients were evaluable. Compared to the his-
torical control group, there were no statistically significant differ-
ences in nausea and vomiting when examining age, disease, gender,
and chemotherapy regimens. There was no correlation between in-
fusion rate and nausea scores, or between individual nausea scores
and those patients who vomited. A trend (p 5 0.05) was noted for
increased nausea scores as the number of bags increased.
Discussion: Only 9/49 (18%) of the study patients had nausea (p\
.0001) compared to 58% from the control group. In addition, only 9/
49 (18%) vomited compared to 33% in the control group.
Conclusion: Although this was a small, non-blinded pilot study, the
results suggest patients who received a single dose of intravenous on-
dansetron had significantly decreased nausea and vomiting during
cryopreserved stem cell infusions. A larger, double-blinded study is
warranted.112
END-OF-LIFE AND PALLIATIVE CARE IN BMT: NURSES NEED EDUCATION
AND SUPPORT
Sprouse, D.O., Thirlwell, S., Beaupierre, A., Lauersdorf, L. Moffitt Can-
cer Center, Tampa, FL
Recently, the Blood and Marrow Transplant (BMT) program at
our NCI-designated Cancer Center increased its inpatient capacity
by 80% and its nursing staff by 50%. Concurrently, treatment pro-
tocols expanded and patients with co-morbidities increased. These
factors have resulted in increased morbidity, mortality, and length
of stay and increased compassion fatigue among old and new BMT
nurses.
Two new BMT nurses expressed concern regarding peers’ com-
passion fatigue and a desire to educate about palliative care (PC)
and end of life (EOL). Partnering with the Clinical Nurse Specialist
(CNS) and Patient Care Manager, staff nurses initiated an EOL/PC
Committee with the goals of staff education and support. Education
has included journal article review and guests such as the Ethics
Committee Chair, Hospice Liaisons, and Palliative Care Nurse Ex-
perts. Members are encouraged to obtain ELNEC (End-of-Life
Nursing Education Consortium) or similar training. Attendees re-
ceive support through an open forum at each monthly meeting to
share concerns about patient deaths, life-threatening complications
or goals of care. Meeting discussions are facilitated by a CNS certi-
fied in Hospice and Palliative Care, ELNEC educators, hospice
nurses, social worker, and Psychiatric CNS. Discussions focus on
expression of emotions, problem-solving and nurse’s role at EOL.
EOL/PC Committee has grown from 4 to 27% of unit staff since
April 2009. Beyond direct education and support at meetings, issues
raised have resulted in care improvement initiatives. Outcomes in-
clude peer education regarding post-mortem care, collaboration
with Medical Leadership to improve communication about futile
care and presentation at Grand Rounds to elevate awareness of
EOL issues. Ongoing initiatives are to develop a tool to assess futility
of care, to identify a Palliative Care Resource Nurse for each shift
and to enhance nurse’s role in completion of Advance Directives.
The unit-based BMTEOL/PCCommittee has successfully raised
awareness and created a forum for discussion of PC and EOL issues.
Though we all strive for cure, we need to acknowledge and support
the reality that all transplants are not successful and are associated
with emotionally and physically devastating complications for the
patient, their family and BMT staff. On our unit, the BMT EOL/
PC Committee is a safe venue for nursing staff to acknowledge this
reality as well as an arena to improve the PC and EOL that we
provide.
